Results 121 to 130 of about 316,189 (194)
In Vivo Ultrasound Characterization of the Tibial Nerve at the Supramalleolar Region
ABSTRACT Background Accurate knowledge of the supramalleolar anatomy of the tibial nerve is essential for safe ultrasound‐guided procedures and proximal nerve interventions in the foot and ankle. However, quantitative in vivo ultrasound reference data describing its positional anatomy at this level remain scarce.
María Benimeli‐Fenollar +6 more
wiley +1 more source
ABSTRACT Objective To determine whether micronutrient intake and/or supplementation is associated with prevalent diabetes‐related foot ulcer (DFU) and/or incident hospitalisation for DFU in type 2 diabetes. Research Design and Methods Participants with type 2 diabetes from the community‐based Fremantle Diabetes Study Phase II (FDS2; 1499 participants ...
Emma J. Hamilton +4 more
wiley +1 more source
Proteomic Signatures of Ectopic Fat Distribution: Tissue‐Specific Drivers and Clinical Implications
Integration of plasma proteomics and multi‐organ MRI in 666 UK Biobank participants, combined with a knockoff‐based causal inference and machine learning framework, reveals organ‐specific drivers of ectopic fat: PLA2G1B (pancreas), ERBB2/IGFBP2 (liver), CA14 (muscle), and NCAM2/TNFRSF10B (pericardium). These drivers engage distinct pathways (e.g., PI3K‐
Bing Zhang +9 more
wiley +1 more source
Evaluation of Topiramate Efficacy on Neuropathic Pain in Patients With Diabetic Polyneuropathy
Polyneuropathy is one of the most common and disabling complications of diabetes. Severe pain is one of the complications of diabetic polyneuropathy .Over the years, many drugs for the treatment of the pain in diabetic neuropathy have been tried. However,
Sedigheh Shamsinejad +4 more
doaj
ABSTRACT Drug Combinations offer increased therapeutic efficacy and reduced toxicity compared with single agents. Understanding a drug combination's mechanisms of action (MoA) can provide important insights into therapeutic efficacy. The MoA of many FDA‐approved drugs, however, often remains unclear.
Rui‐Sheng Wang +5 more
wiley +1 more source
Pathogenetic treatment of diabetic polyneuropathy
The authors have studied the effect of mildronat and thiotriazolin on the processes of lipid peroxidation, the oxidative modification of proteins and the state of the blood antioxidant system 3 and 6 months following a course of multimodality treatment ...
Pavlovych, L.B., Bilous, I.I.
core +2 more sources
Liquid crystal thermography in neuropathic assessment of the diabetic foot. [PDF]
Primary aetiologic factors of diabetic foot disease include peripheral neuropathy and peripheral vascular disease. Assessment of circulation, neuropathy, and foot pressure is employed routinely to determine the risk of foot ulceration in the patient ...
Bharara, Manish
core +3 more sources
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier +4 more
wiley +1 more source
There are no tools to support early detection of ATTRv signs/symptoms or to identify risk of transition to clinically detectable disease in carriers of pathogenic ATTRv variants. This retrospective cohort study describes the ACNA, a brief 23‐item assessment for use in routine clinical visits.
Isabel Conceição +8 more
wiley +1 more source
ABSTRACT Background and Aims In ADHERE, subcutaneous efgartigimod PH20 (1000 mg once weekly) was effective and well tolerated in participants with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). ADHERE+ is an open‐label extension of ADHERE assessing long‐term safety and efficacy. Methods Eligible participants from ADHERE run‐in period
Jeffrey A. Allen +8 more
wiley +1 more source

